Adam Levy,

Adam Levy is a biopharmaceutical expert with over 25 years of industry experience, including at Zentalis Pharmaceuticals, Turning Point Therapeutics and Gilead Sciences. He currently serves as senior vice president and head of investor relations and corporate affairs at Acrivon Therapeutics, a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine using its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3). Prior to joining Acrivon, Levy was senior vice president of investor relations at Zentalis Pharmaceuticals and held positions of increasing responsibility in corporate strategy and corporate development at Pfizer, Novartis AG, Alexion Pharmaceuticals, and Gilead Sciences. He also served as an engagement manager at McKinsey and Company, focusing on supporting clients in the pharmaceutical industry to identify long-term growth strategies and opportunities.

Biography:  https://finance.yahoo.com/news/acrivon-therapeutics-announces-appointment-adam-120000631.html

88%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

95%

Examples:

  • In order to support third-party large language models (LLMs) and its own more advanced LLM, Apple created Private Cloud Compute (PCC). The system uses Apple servers that also deploy the tech titan's own chip designs. . .

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

85%

Examples:

  • Apple unveiled its new artificial intelligence features called 'Apple Intelligence' at its Worldwide Developers Conference.

Deceptions

65%

Examples:

  • There’s a long runway for Apple to grow AI features through third-party integrations. Just consider the phenomenal growth of the App Store over the past 15 years.

Recent Articles

Apple's Privacy-First Approach to AI vs. Google's Hybrid Strategy: A New Era in Smartphone Tech

Apple's Privacy-First Approach to AI vs. Google's Hybrid Strategy: A New Era in Smartphone Tech

Broke On: Thursday, 04 July 2024 Apple's privacy-focused iOS 18 and macOS Sequoia introduce Apple Intelligence, a new AI feature with on-screen Siri awareness, while Google maintains user control through hybrid AI and cloud security. Apple's partnership with OpenAI raises privacy concerns, but its extensive private infrastructure bolsters security. The rollout of these advanced AI capabilities could boost demand for TSMC chips.